whether patients should undergo genetic testing to determine their warfarin dose

October 2007

Experts are now debating whether patients should undergo genetic testing to determine their warfarin dose.

Warfarin doses are mostly titrated by trial and error.

Now the FDA is suggesting lower doses for patients with certain genetic variations.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote